November 23, 2017:
Mylan has advised that both EpiPen 300mcg and EpiPen Jr 150mcg adrenaline (epinephrine) autoinjectors have now been shipped to Australian pharmacy wholesalers and stock will become available to pharmacies shortly. The supply of no-charge EpiPen® Jr 150mcg, expiring 30 November 2017, has therefore ceased.
Further stock will be released over the coming weeks. Due to demand, orders will be filled as efficiently as possible, as they work to restore the supply.
Please note that New Zealand has not been affected by these temporary supply issues.
ASCIA recommends EpiPen® Jr 150mcg for patients weighing between 10-20kgs and EpiPen® 300mcg for patients 20kgs and over.